[
  {
    "ts": null,
    "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=cbe7229cf4a83c343dee6682360bc8315f813600955351d17deef73d3e626a78",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734626220,
      "headline": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "id": 132065763,
      "image": "",
      "related": "ABT",
      "source": "MarketWatch",
      "summary": "Abbott Laboratories stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=cbe7229cf4a83c343dee6682360bc8315f813600955351d17deef73d3e626a78"
    }
  },
  {
    "ts": null,
    "headline": "4 Healthcare Technology Innovators to Invest in Before the New Year",
    "summary": "Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.",
    "url": "https://finnhub.io/api/news?id=0ff74ee0155e7fc326656d895dfa6be9472e827466934509bdf84d102979bd6d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734623760,
      "headline": "4 Healthcare Technology Innovators to Invest in Before the New Year",
      "id": 132060267,
      "image": "https://media.zenfs.com/en/zacks.com/82aa990112b541acec95ecc4c3df7065",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Here, we have presented four healthcare technology stocks for stable portfolio gains in 2025: VCYT, OMCL, MASI and ABT.",
      "url": "https://finnhub.io/api/news?id=0ff74ee0155e7fc326656d895dfa6be9472e827466934509bdf84d102979bd6d"
    }
  },
  {
    "ts": null,
    "headline": "Reasons to Retain ABT Stock in Your Portfolio Now",
    "summary": "Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.",
    "url": "https://finnhub.io/api/news?id=b41515f31fcc66520a2f8f9b711c4eb19eac165a27058f8c488c8b2e9b391673",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734614100,
      "headline": "Reasons to Retain ABT Stock in Your Portfolio Now",
      "id": 132061563,
      "image": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Investors feel optimistic about Abbott's robust strength in the EPD and Nutrition businesses. Yet, unfavorable forex impacts are concerning.",
      "url": "https://finnhub.io/api/news?id=b41515f31fcc66520a2f8f9b711c4eb19eac165a27058f8c488c8b2e9b391673"
    }
  },
  {
    "ts": null,
    "headline": "2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond",
    "summary": "Whatever the answer is, it probably won't be dividend investing.  Let's consider two income-focused corporations whose shares are worth holding on to well beyond next year: AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT).  AbbVie, a former division of Abbott Laboratories, became a stand-alone company in 2013.",
    "url": "https://finnhub.io/api/news?id=f632dd48e8fe696ce52c4f3aa1c835a1e1cc2a98041ed2d2398f4e37432c52bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734606000,
      "headline": "2 Top Dividend Stocks to Buy and Hold Through 2025 and Beyond",
      "id": 132057954,
      "image": "https://g.foolcdn.com/editorial/images/800762/nurse-holding-patients-hands.jpg",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Whatever the answer is, it probably won't be dividend investing.  Let's consider two income-focused corporations whose shares are worth holding on to well beyond next year: AbbVie (NYSE: ABBV) and Abbott Laboratories (NYSE: ABT).  AbbVie, a former division of Abbott Laboratories, became a stand-alone company in 2013.",
      "url": "https://finnhub.io/api/news?id=f632dd48e8fe696ce52c4f3aa1c835a1e1cc2a98041ed2d2398f4e37432c52bb"
    }
  }
]